Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott

Core Insights - Medtronic has launched the MiniMed™ 780G system integrated with Abbott's Instinct sensor in the U.S., marking a significant advancement in diabetes management technology [1][2][3] Product Launch - The MiniMed™ 780G system is now commercially available following FDA clearance, allowing for integration with the Instinct sensor [1][2] - The Instinct sensor is noted for being the world's smallest and thinnest continuous glucose monitor (CGM), with a wear time of up to 15 days [3][6] Technology Features - The MiniMed™ 780G system automates insulin adjustments every five minutes based on real-time glucose readings, which helps users manage diabetes more effectively [3][6] - The combination of the Instinct sensor and the MiniMed™ 780G system has received positive feedback from early users, indicating improved time in glucose range for patients [4][5] Market Positioning - The launch of the Instinct sensor expands Medtronic's sensor portfolio, which includes the recently launched Simplera Sync™ sensor and the Guardian™ 4 sensor, enhancing the company's offerings in diabetes care [4][5] - Medtronic aims to provide a personalized diabetes management experience, allowing users to choose solutions that best fit their lifestyles [5][7] Company Mission - Medtronic's mission is to make diabetes management more predictable and to improve the quality of life for individuals living with diabetes through advanced technology and support [7][8]